High Tower Advisors, LLC Atea Pharmaceuticals, Inc. Transaction History
High Tower Advisors, LLC
- $71.6 Billion
- Q4 2024
A detailed history of High Tower Advisors, LLC transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 50,087 shares of AVIR stock, worth $149,259. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,087Holding current value
$149,259% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AVIR
# of Institutions
110Shares Held
53.4MCall Options Held
900Put Options Held
126K-
Black Rock Inc. New York, NY9.12MShares$27.2 Million0.0% of portfolio
-
Bml Capital Management, LLC Zionsville, IN7.61MShares$22.7 Million15.83% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.44MShares$16.2 Million0.79% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.85MShares$14.5 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA4.61MShares$13.7 Million1.31% of portfolio
About Atea Pharmaceuticals, Inc.
- Ticker AVIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,258,600
- Market Cap $248M
- Description
- Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...